All News

Found 613 articles

• Evotec AG, Roche's Alzheimer's Hopeful Fails Another Trial

  7/2/2015

• Axovant Takes Center Stage With Biggest Biotech IPO Ever, Baby-Faced CEO

  6/15/2015

• Buoyed by Biogen, Roche to Take Another Stab at Anti-Amyloid Alzheimer’s Drugs

  6/10/2015

• Cognoptix Release: "2015 World Medical Innovation Forum" Cites "Early Diagnosis And Treatment Of Alzheimer’s Disease" As The Top Field Where Breakthroughs Will Be Made

  5/11/2015

• Advancing Biogen’s Alzheimer’s Treatment Could Cost $2.5 Billion Before Knowing if the Drug Works

  4/28/2015

• In Fight Against Alzheimer's, $100 Million Genentech Trial in Colombia May Be Ground Zero

  4/28/2015

• Biogen Reports First Quarter 2015 Revenues Of $2.6 Billion

  4/24/2015

• Roche Still Bullish on Alzheimer’s Research After Biogen’s Successful Clinical Trial

  4/22/2015

• Raising $10M in Series A, Alzheon CEO Bets He Can Beat Biogen With World's First Alzheimer's Drug

  4/8/2015

• Cambridge Market Heats Up As BioMed Signs Biogen

  4/3/2015

• Biogen Alzheimer's Drug Aducanumab Exceeds Expectations

  3/25/2015

• Biogen Drops Idec From Corporate Name, Expands Ambitions in Alzheimer's, ALS

  3/24/2015

• Biogen Idec Presents Positive Interim Results From Phase 1B Study Of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) At 2015 AD/PD Conference

  3/20/2015